Are 12-17 year olds soon vaccinated with Moderna?
The American biotechnology company assured Tuesday that according to the full results of clinical trials, its vaccine against Covid-19 had been shown to be "highly effective in preventing Covid-19 in adolescents".
"We are going to submit these results to the FDA (the American Medicines Agency) and to regulators around the world in early June and request an authorization" to use his vaccine for this age group, said the boss of Moderna, Stéphane Bancel, quoted in a press release.
Another vaccine, that of Pfizer / BioNTech, is already authorized for adolescents in several countries, including the United States.
100% effective with two doses
The Moderna study involved more than 3,700 participants aged 12 to 17 in the United States, two-thirds of whom received the vaccine, and one-third received a placebo.
"After two doses, no case of Covid-19 was observed in the vaccinated group (...) against 4 cases in the placebo group, resulting in an efficacy of the vaccine of 100% 14 days after the second dose", declared Moderna in its press release.
After a dose, an efficacy of 93% was observed, specifies the company.
The vaccine was "generally well tolerated" and "no concerns about its safety have been identified so far," she said.
The side effects observed were the same as in adults (pain at the site of the injection, fatigue, chills, etc.).
Health
Coronavirus: Teachers, police officers, cashiers ... Priority professions can be vaccinated regardless of age
Society
Vaccination in Ile-de-France: Even before opening to all, those under 50 flock to vaccines
Covid 19
Coronavirus
Teenager
Health
Vaccine
Anti-covid vaccine
Vaccination
Moderna
Pharmaceutical industry